VisionPoint Advisory Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$267K Buy
1,268
+146
+13% +$31.3K 0.04% 391
2026
Q1
$248K Sell
1,122
-99
-8% -$24.2K 0.05% 376
2025
Q4
$310K Buy
1,221
+93
+8% +$23.4K 0.06% 296
2025
Q3
$279K Buy
1,128
+54
+5% +$12.9K 0.06% 305
2025
Q2
$258K Buy
+1,074
New +$250K 0.06% 299
2025
Q1
Sell
-507
Closed -$103K 298
2024
Q4
$103K Buy
507
+84
+20% +$18.4K 0.04% 231
2024
Q3
$103K Buy
423
+137
+48% +$32K 0.03% 222
2024
Q2
$62.8K Buy
286
+33
+13% +$7.17K 0.02% 247
2024
Q1
$56.9K Buy
253
+97
+62% +$21.9K 0.02% 251
2023
Q4
$34.3K Buy
+156
New +$33K 0.01% 301

Other funds holding STE

VisionPoint Advisory Group's STE Position: Q2 2026 in Review

VisionPoint Advisory Group increased its Steris (STE) stake by 13% in Q2 2026, buying an estimated $31.3K and bringing the position to 1,268 shares worth $267K. The position accounts for 0.04% of the portfolio, ranked #391.

VisionPoint Advisory Group first reported a position in STE in Q4 2023 and has held it in 10 quarters since. The position peaked at $310K in Q4 2025. 91 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • VisionPoint Advisory Group held 1,268 shares of Steris worth $267K as of Q2 2026.
  • VisionPoint Advisory Group bought 146 Steris shares in Q2 2026, an estimated $31.3K.
  • Steris made up 0.04% of VisionPoint Advisory Group's portfolio in Q2 2026, its #391 holding.
  • VisionPoint Advisory Group first reported a position in Steris in Q4 2023 and has held it in 10 quarters since.
  • VisionPoint Advisory Group's Steris position peaked at $310K in Q4 2025.
  • 91 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.